Literature DB >> 30293073

Success Rates for Retinal Detachment Repair in Alberta: A Physician Learning Program Initiative.

Assaf Dotan1,2, Dianne Johnson3, Amin Kherani4, Kahrram Jahangir3, Matthew T S Tennant5.   

Abstract

OBJECTIVE: To identify primary surgical success rates for retinal detachment repair in Alberta and compare functional outcomes of methods of repair.
METHODS: Data was retrospectively extracted from the Alberta Health Services Discharge Abstract Database and the National Ambulatory Care Reporting System for all patients diagnosed with retinal detachment and vitreoretinal procedures during the 2008/09 to 2012/13 fiscal years.
RESULTS: Of the 5,433 surgeries for retinal detachment identified, 279 were excluded due to invalid provincial health numbers, unidentified procedure location, and/or treating physician other than an Alberta retina surgeon. The final analysis included 4,336 detachments in 4,020 patients. The average primary retinal detachment success rate was 84.9% (3,680/4,336). Primary success rates varied between vitrectomy only (84.9%, 2,149/2,532), vitrectomy and scleral buckle (85.5%, 818/957), and scleral buckle (84.4%, 702/832).
CONCLUSIONS: Alberta retina surgeons have an average primary success rate of 84.9% (3,680/4,336) for repair of retinal detachments. This result is in keeping with other published retinal detachment success rate studies.
© 2018 S. Karger AG, Basel.

Entities:  

Keywords:  Alberta; Physician Learning Program; Retinal detachment; Scleral buckle; Success rate; Vitrectomy

Mesh:

Year:  2018        PMID: 30293073     DOI: 10.1159/000492538

Source DB:  PubMed          Journal:  Ophthalmologica        ISSN: 0030-3755            Impact factor:   3.250


  2 in total

1.  [Retinal detachment surgery: trends over 15 years].

Authors:  Viola Radeck; Horst Helbig; Teresa Barth; Maria-Andreea Gamulescu; Philipp Prahs; David Maerker
Journal:  Ophthalmologe       Date:  2021-06-17       Impact factor: 1.059

2.  The learning curve of retinal detachment surgery.

Authors:  Viola Radeck; Horst Helbig; Teresa Barth; Maria-Andreea Gamulescu; David Maerker; Philipp Prahs
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2021-02-05       Impact factor: 3.117

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.